EGFR and thyroid cancer: This consequently resulted in promoting the proliferative, migrative, and invasive abilities of thyroid cancer cells in vitro, and augmenting the tumorigenesis in vivo via activating epidermal growth factor receptor (EGFR)/PI3K/Akt pathway [114].